ATC Group: D03AX Other cicatrizants

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D03AX in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D03 Preparations for treatment of wounds and ulcers
3 D03A Cicatrizants
4 D03AX Other cicatrizants

Group D03AX contents

Code Title
D03AX01 Cadexomer iodine
D03AX02 Dextranomer
D03AX03 Dexpanthenol
D03AX04 Calcium pantothenate
D03AX05 Hyaluronic acid
D03AX06 Becaplermin
D03AX09 Crilanomer
D03AX10 Enoxolone
D03AX11 Tetrachlorodecaoxide
D03AX12
D03AX13
D03AX14
D03AX15
D03AX16

Active ingredients in D03AX

Active Ingredient Description
Becaplermin

Becaplermin a recombinant human platelet-derived growth factor (rhPDGF-BB) for topical administration. Becaplermin has biological activity similar to that of endogenous platelet-derived growth factor, which includes promoting the chemotactic recruitment and proliferation of cells involved in wound repair and enhancing the formation of granulation tissue.

Beremagene geperpavec

Dystrophic epidermolysis bullosa (DEB) is caused by mutation(s) in the COL7A1 gene, which results in reduced or absent levels of biologically active COL7. Upon topical application to the wounds, beremagene geperpavec can transduce both keratinocytes and fibroblasts. Following entry of beremagene geperpavec into the cells, the vector genome is deposited in the nucleus. Once in the nucleus, transcription of the encoded human COL7A1 is initiated. The resulting transcripts allow for production and secretion of COL7 by the cell in its mature form. These COL7 molecules arrange themselves into long, thin bundles that form anchoring fibrils. The anchoring fibrils hold the epidermis and dermis together and are essential for maintaining the integrity of the skin.

Betulin

Betulin accelerated re-epithelialization in an in vitro wound scratch assay using human primary keratinocytes at the dosage of 1 ฮผg/ml, and in a porcine ex vivo wound healing model at the dosage of 10 ยตg/ml. The precise mechanism of action of the active substance in wound healing in humans is not known.

Cadexomer iodine

In contact with wound exudate cadexomer iodine absorbs fluid, removes exudate, pus and debris from the wound surface. Iodine is physically immobilised within the matrix of the dry cadexomer iodine and is slowly released in an active form during uptake of wound fluid. This mechanism of release provides antibacterial activity both at the wound surface and within the formed gel.

Centella asiatica

Centella asiatica is a medicinal plant that has been used in folk medicine for hundreds of years as well as in scientifically oriented medicine. The active compounds include pentacyclic triterpenes, mainly asiaticoside, madecassoside, asiatic and madecassic acids. Centella asiatica is effective in improving treatment of small wounds, hypertrophic wounds as well as burns, psoriasis and scleroderma. The mechanism of action involves promoting fibroblast proliferation and increasing the synthesis of collagen and intracellular fibronectin content and also improvement of the tensile strength of newly formed skin as well as inhibiting the inflammatory phase of hypertrophic scars and keloids.

Dexpanthenol

Dexpanthenol is converted in tissues to pantothenic acid, a component of coenzyme A (CoA) that is essential to normal epithelial function, increased fibroblast proliferation and accelerated re-epithelialization in wound healing.

Enoxolone

Enoxolone is a pentacyclic triterpenoid aglycone metabolite of glycyrrhizin, which is a product of the plant Glycyrrhiza glabra (licorice), with potential expectorant, and gastrokinetic activities. After administration, enoxolone inhibits the metabolism of prostaglandins by both 15-hydroxyprostaglandin dehydrogenase [NAD] and prostaglandin reductase 2.

Hyaluronate sodium
Isoexenylonafthazarines
Trafermin
Trolamine
Pantothenic acid

Pantothenic acid is incorporated into co-enzyme A and is involved in metabolic pathways involving acetylation which includes detoxification of drug molecules and biosynthesis of cholesterol, steroid hormones, mucopolysaccharides and acetylcholine. CoA has an essential function in lipid metabolism.

Related product monographs

Title Information Source Document Type  
BIAFINE Emulsion for cutaneous application Medicines Authority (MT) MPI, EU: SmPC
EPISALVAN Gel European Medicines Agency (EU) MPI, EU: SmPC
FILSUVEZ Gel European Medicines Agency (EU) MPI, EU: SmPC
IODOFLEX Impregnated dressing Health Products Regulatory Authority (IE) MPI, EU: SmPC
SUPLASYN Solution for injection Web Search MPI, EU: SmPC
VYJUVEK Kit, biological suspension and excipient gel for topical application FDA, National Drug Code (US) MPI, US: SPL/PLR